We were delighted to catch up with Dr Pinkal Desai (Weill Cornell Medical College, New York City, NY, USA) to discuss the report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub on clinical predictors of outcome in adult patients with acute leukemias and myelodysplastic syndrome and COVID-19 infection.
Questions
1. Prior to your study, what was known about outcomes with COVID-19 in patients with acute myeloid leukemia, acute lymphocytic leukemia and myelodysplastic syndromes? 00:13-01:35
2. What were the aims and methodology of your study? 01:35-03:08
3. What were the findings in terms of COVID-19 severity? 03:08-04:20
4. What were the findings in terms of COVID-19 mortality? 04:20-07:32
5. What recommendations would you suggest based on these findings? 07:32-10:00
Speaker Disclosure: Pinkal Desai has no financial or non-financial conflicts of interest to declare in relation to this video.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.
Filmed in coverage of the 63rd ASH Annual Meeting & Exposition
